Bard Associates Inc. Sells 1,040 Shares of Stericycle, Inc. (NASDAQ:SRCL)

Bard Associates Inc. trimmed its holdings in shares of Stericycle, Inc. (NASDAQ:SRCL) by 4.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 23,570 shares of the business services provider’s stock after selling 1,040 shares during the period. Bard Associates Inc.’s holdings in Stericycle were worth $1,438,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Clearstead Trust LLC bought a new stake in shares of Stericycle during the first quarter valued at approximately $25,000. Headlands Technologies LLC bought a new position in shares of Stericycle during the first quarter valued at approximately $44,000. International Assets Investment Management LLC purchased a new stake in shares of Stericycle during the 2nd quarter worth $45,000. Quest Partners LLC grew its position in shares of Stericycle by 4,172.7% in the 2nd quarter. Quest Partners LLC now owns 940 shares of the business services provider’s stock worth $55,000 after buying an additional 918 shares during the last quarter. Finally, Summit Securities Group LLC acquired a new position in shares of Stericycle during the second quarter worth $58,000. Institutional investors own 98.82% of the company’s stock.

Stericycle Stock Performance

Shares of SRCL stock opened at $61.98 on Friday. Stericycle, Inc. has a one year low of $37.78 and a one year high of $61.99. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.13 and a current ratio of 1.20. The firm’s 50 day moving average price is $61.36 and its 200-day moving average price is $57.52. The firm has a market cap of $5.75 billion, a P/E ratio of 163.11, a P/E/G ratio of 3.38 and a beta of 1.10.

Analysts Set New Price Targets

Separately, StockNews.com initiated coverage on Stericycle in a research note on Tuesday. They issued a “hold” rating for the company. One analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $74.00.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.